PUBLISHER: TechNavio | PRODUCT CODE: 1723094
PUBLISHER: TechNavio | PRODUCT CODE: 1723094
The uterine fibroid (UF) treatment device market is forecasted to grow by USD 3358.2 mn during 2024-2029, accelerating at a CAGR of 9.6% during the forecast period. The report on the uterine fibroid (UF) treatment device market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of uterine fibroids, increase in healthcare expenditure, and growing awareness about uterine fibroid treatment.
Market Scope | |
---|---|
Base Year | 2025 |
End Year | 2029 |
Series Year | 2025-2029 |
Growth Momentum | Accelerate |
YOY 2025 | 8.8% |
CAGR | 9.6% |
Incremental Value | $3358.2 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's uterine fibroid (UF) treatment device market is segmented as below:
By Therapeutic Area
By Technology
By End-user
By Geographical Landscape
This study identifies the improving healthcare systems in emerging economies as one of the prime reasons driving the uterine fibroid (UF) treatment device market growth during the next few years. Also, increasing preference for minimally invasive procedures and growing adoption of advanced technologies will lead to sizable demand in the market.
The report on the uterine fibroid (UF) treatment device market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading uterine fibroid (UF) treatment device market vendors that include AbbVie Inc., Boston Scientific Corp., Chongqing Haifu Medical Technology Co. Ltd., Conmed Corp., CooperSurgical Inc., Hologic Inc., INSIGHTEC Ltd., KARL STORZ SE and Co. KG, Lumenis Be Ltd., Medtronic Plc, Merit Medical Systems Inc., Minerva Surgical Inc., Olympus Corp., Profound Medical Corp., and Stryker Corp.. Also, the uterine fibroid (UF) treatment device market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: